# US 2015/0086490 A1 · Oral care compositions and methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0086490 A1
- Document ID: US20150086490A1
- Status: Published application
- Kind: A1
- Application number: 14/505,496
- Filed: 2014-10-02
- Published: 2015-03-26
- Earliest claimed: 2009-12-21
- Assignees: Colgate-Palmolive Company
- Applicants: Colgate-Palmolive Company
- Inventors: Wei Wang; Virginia Barnes; Harsh M. Trivedi; Tao Xu
- Web page: https://patentgrep.com/patent/US20150086490A1

## CPC

- A61K 8/42: Amides
- A61K 8/347: {Phenols}
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A61K 31/265: of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A61K 31/27: of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A61K 36/324: Boswellia, e.g. frankincense
- A61K 36/45: Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- C07C 69/96: Esters of carbonic or haloformic acids
- C07C 271/38: with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- A61K 8/37: Esters of carboxylic acids
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Described herein are compositions comprising a MMP-13 inhibitor, and methods of using the same.

## Claims

### Claim 1

A composition comprising a therapeutically effective amount of a MMP-13 inhibitor, and an orally acceptable carrier, wherein the MMP-13 inhibitor is 4-acetamidophenyl 2-isopropyl-5-methylcyclohexyl carbonate.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the composition further comprises an MMP-13 inhibitor selected from the group consisting of cranberry extract non-dialyzable material, acetyl keto β-boswellic acid, resveratrol, and 2-isopropyl-5-methlylcyclohexyl 2-hydroxyphenylcarbamate, and combinations thereof.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the MMP-13 inhibitor comprises cranberry extract non-dialyzable material.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the MMP-13 inhibitor comprises acetyl keto β-boswellic acid.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the MMP-13 inhibitor comprises resveratrol.

### Claim 6 (depends on 2)

The composition of claim 2, wherein the MMP-13 inhibitor comprises 2-isopropyl-5-methylcyclohex 2-hydroxyphenylcarbamate.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the composition is a dentifrice.

### Claim 8 (depends on 7)

The composition of claim 7, wherein the dentifrice is selected from the group consisting of: toothpaste; deep striped toothpaste; surface striped toothpaste; multi-layered toothpaste; a gel surrounding toothpaste; powder; beads; mouthwash; mouth rinses; lozenge; dental gel; a periodontal gel; a liquid suitable for painting a dental surface; a chewing gum; a dissolvable, partially dissolvable or non-dissolvable film or strip; a wafer; a wipe or towelette; an implant; a foam; a troche; a dental floss, liquid formulated for oral application in a small portable bottle; liquid formulated for oral application in a small portable drop-generating bottle; a soft pliable tablet; or a combination of two or more thereof.

### Claim 9

A method for treating a condition associated with aberrant MMP-13 expression comprising administering to a subject a therapeutically effective amount of acetyl keto β-bosweilic acid, wherein the acetyl ketop-boswellic acid is administered in the form of a dentifrice composition.

### Claim 10

A method for treating a condition associated with aberrant MMP-13 expression comprising administering to a subject to therapeutically effective amount of 2-isopropyl-5-methylcyclohexyl2-hydroxy phenylcarbamate, wherein the condition associated with aberrant MMP-13 expression is selected from the group consisting of degradation of the extracellular matrix, loss of attachment one or more teeth, tooth loss, tooth mobility, pocket formation, and combinations of two or more thereof, and wherein the 2-isopropyl-5-methylcyclohexyl 2-hydroxyphenylcarbamate is administered in the form of a dentifrice composition.

### Claim 11 (depends on 9)

The method of claim 9, further comprising admininistering to the subject a therapeutically active amount of one or more of cranberry extract non-dialyzable material, resveratrol, 2-isopropyl-5-methylcyclohexyl 2-hydroxyphenylcarbamate, and 4-acetamidophenyl 2-isopropyl-5-methylcyclohexyl carbonate.

### Claim 12 (depends on 10)

The method of claim 10, further comprising admininistering to the subject a therapeutically active amount of one or more of cranberry extract non-dialyzable material, resveratrol, acetyl keto β-boswellic acid, and 4-acetamidophenyl 2-isopropyl-5-methylcyclohexyl carbonate.
